- Home
- PCRX vs NVRI Comparison
PCRX vs NVRI Comparison
Compare PCRX & NVRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- NVRI
- Stock Information
- Founded
- PCRX 2006
- NVRI 1853
- Country
- PCRX United States
- NVRI United States
- Employees
- PCRX N/A
- NVRI N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- NVRI Diversified Commercial Services
- Sector
- PCRX Health Care
- NVRI Miscellaneous
- Exchange
- PCRX Nasdaq
- NVRI Nasdaq
- Market Cap
- PCRX 1.2B
- NVRI 750.9M
- IPO Year
- PCRX 2011
- NVRI N/A
- Fundamental
- Price
- PCRX $26.59
- NVRI $9.32
- Analyst Decision
- PCRX Buy
- NVRI Hold
- Analyst Count
- PCRX 10
- NVRI 1
- Target Price
- PCRX $29.30
- NVRI $10.00
- AVG Volume (30 Days)
- PCRX 892.8K
- NVRI 834.8K
- Earning Date
- PCRX 02-27-2025
- NVRI 02-20-2025
- Dividend Yield
- PCRX N/A
- NVRI N/A
- EPS Growth
- PCRX N/A
- NVRI N/A
- EPS
- PCRX N/A
- NVRI N/A
- Revenue
- PCRX $694,957,000.00
- NVRI $2,086,473,000.00
- Revenue This Year
- PCRX $5.14
- NVRI $16.52
- Revenue Next Year
- PCRX $2.44
- NVRI $0.21
- P/E Ratio
- PCRX N/A
- NVRI N/A
- Revenue Growth
- PCRX 4.40
- NVRI N/A
- 52 Week Low
- PCRX $11.16
- NVRI $6.57
- 52 Week High
- PCRX $31.67
- NVRI $12.79
- Technical
- Relative Strength Index (RSI)
- PCRX 77.75
- NVRI 60.95
- Support Level
- PCRX $25.06
- NVRI $8.91
- Resistance Level
- PCRX $27.10
- NVRI $9.93
- Average True Range (ATR)
- PCRX 1.45
- NVRI 0.37
- MACD
- PCRX 0.28
- NVRI -0.00
- Stochastic Oscillator
- PCRX 86.23
- NVRI 61.80
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About NVRI Enviri Corporation
Enviri Corp engages in providing a broad range of environmental services and related solutions. The company's current operations consist of three divisions: Harsco Environmental, Harsco Rail, and Clean Earth. The company serves a diverse customer base by offering critical recycle and reuse solutions for their waste streams, enabling customers to address their complex environmental challenges.